The accompanying consolidated financial statements include the accounts of Scientific Industries, Inc., Altamira Instruments, Inc. (“Altamira”), a Delaware corporation and wholly-owned subsidiary, and Scientific Bioprocessing, Inc. (“SBI”), a Delaware corporation and wholly-owned subsidiary, and Scientific Packaging Industries, Inc., an inactive wholly-owned subsidiary (all collectively referred to as the “Company”).
All material intercompany balances and transactions have been eliminated.
In February 2016, the FASB issued ASU No.
In August 2016, the FASB issued ASU 2016-15, “Classification of Certain Cash Receipts and Cash Payments”.
This update provides guidance on how to record eight specific cash flow issues.
This update is effective for fiscal years beginning after December 15, 2017, and interim periods within those fiscal years.
In November 2016, the FASB issued ASU 2016-18, “Statement of Cash Flows (Topic 230)”, requiring that the statement of cash flows explain the change in the total cash, cash equivalents, and amounts generally described as restricted cash or restricted cash equivalents.
Trade accounts receivable, current of $67,100 and $278,200, and trade accounts receivable, long term of $245,400 for both periods were reclassified to contract assets, current; and contract assets, less current portion, respectively, on the balance sheet as of September 30, and June 30, 2018.
In addition the Company’s Bioprocessing Systems Operations’ revenues are comprised of royalty revenues.
All revenue is recognized when the Company satisfies its performance obligation(s) under the contract (either implicit or explicit) by transferring the promised product or service to its customer either when (or as) its customer obtains control of the product or service.
A contract’s transaction price is allocated to each distinct performance obligation.
Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring products or providing services.
As such, revenue is recorded net of returns, allowances, customer discounts, and incentives.
Fair value measurements do not include transaction costs.
Level 1 - Inputs that are based upon unadjusted quoted prices for identical instruments traded in active markets.